首页 > 最新文献

Lancet Regional Health-Americas最新文献

英文 中文
Conditional cash transfer interventions to support syphilis treatment in vulnerable populations: a quasi-experimental study among displaced and host communities in a border city of Colombia 支持弱势群体梅毒治疗的有条件现金转移干预措施:哥伦比亚边境城市流离失所者和收容社区的准实验研究
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-14 DOI: 10.1016/j.lana.2025.101301
Merike Blofield , Andrea L. Wirtz , Magaly Pedraza , Rafael Olarte , Doris Parada

Background

Syphilis incidence is increasing globally; however, cost and time are significant barriers to treatment completion rates among vulnerable populations, including displaced populations and host communities. To inform public health strategies, we aimed to test whether conditional cash transfers (CCT) increased completion of syphilis treatment among a community sample in a border city of Colombia.

Methods

We embedded a quasi-experimental trial of a CCT intervention in a community sexual health program serving participants aged 14 years and older in low-income settlements around Cúcuta, Colombia in 2023. The program included workshops and syphilis screening. Individuals with laboratory-confirmed syphilis were eligible for inclusion in the trial. Both control and CCT arms provided syphilis diagnostics, counseling and free treatment. CCT consisted of cash payments of USD$12.69 for completion of each of two follow-up treatments. We used generalized linear models to estimate the effect of CCT on treatment completion, defined as three doses of penicillin.

Findings

Of 1751 workshop participants, 114 had laboratory-confirmed syphilis and were enrolled in the trial. Participants were 56% female (64/114) and 44% male (50/114), with 6 participants (5.3%) identifying as transgender, regardless of sex at birth. Participants included 47% Venezuelan migrants staying in Cúcuta (53/114), 26% Colombian returnees (30/114), and 19% Colombians from the host community (22/114). Data on ethnicity was not collected. Median age was 34.5 years (IQR: 25.0–46.0). More than three-quarters (78%, 39/50) of CCT participants completed the three-dose treatment regimen compared to 45% (29/64) of control participants, a risk difference of 33% (p < 0.001). In adjusted models, CCT-assigned participants had a 36% higher treatment completion rate compared to control-assigned participants (adjusted risk difference: aRD: 0.36, 95% CI: 0.19–0.53).

Interpretation

Conditional cash transfers might enhance syphilis treatment adherence among populations facing socioeconomic challenges.

Funding

German Development Cooperation Agency, Deutsche Gesellschaft für Internationale Zusammenarbeit.
全球范围内梅毒发病率呈上升趋势;然而,成本和时间是影响弱势群体(包括流离失所者和收容社区)治疗完成率的重大障碍。为了为公共卫生策略提供信息,我们旨在测试有条件现金转移支付(CCT)是否能提高哥伦比亚边境城市社区样本中梅毒治疗的完成度。方法我们在2023年哥伦比亚Cúcuta附近低收入定居点的一个社区性健康项目中嵌入了一项有条件现金转移支付干预的准实验试验,该项目的参与者年龄在14岁及以上。该计划包括研讨会和梅毒筛查。实验室确诊的梅毒患者符合纳入试验的条件。对照组和有条件现金资助组均提供梅毒诊断、咨询和免费治疗。有条件现金转移支付包括完成两项后续治疗的现金支付12.69美元。我们使用广义线性模型来估计CCT对治疗完成的影响,定义为三剂青霉素。在1751名研讨会参与者中,有114名实验室确认患有梅毒并参加了试验。参与者中56%为女性(64/114),44%为男性(50/114),6名参与者(5.3%)认为自己是变性人,与出生时的性别无关。参与者包括47%停留在Cúcuta(53/114)的委内瑞拉移民,26%返回的哥伦比亚人(30/114)和19%来自收容社区的哥伦比亚人(22/114)。没有收集种族数据。中位年龄34.5岁(IQR: 25.0 ~ 46.0)。超过四分之三(78%,39/50)的CCT参与者完成了三剂量治疗方案,而对照组参与者的这一比例为45%(29/64),风险差异为33% (p < 0.001)。在调整后的模型中,cct分配的参与者的治疗完成率比对照组分配的参与者高36%(调整后的风险差异:aRD: 0.36, 95% CI: 0.19-0.53)。有条件的现金转移可能会提高面临社会经济挑战的人群对梅毒治疗的依从性。资助:德国发展合作署,德国国际合作机构。
{"title":"Conditional cash transfer interventions to support syphilis treatment in vulnerable populations: a quasi-experimental study among displaced and host communities in a border city of Colombia","authors":"Merike Blofield ,&nbsp;Andrea L. Wirtz ,&nbsp;Magaly Pedraza ,&nbsp;Rafael Olarte ,&nbsp;Doris Parada","doi":"10.1016/j.lana.2025.101301","DOIUrl":"10.1016/j.lana.2025.101301","url":null,"abstract":"<div><h3>Background</h3><div>Syphilis incidence is increasing globally; however, cost and time are significant barriers to treatment completion rates among vulnerable populations, including displaced populations and host communities. To inform public health strategies, we aimed to test whether conditional cash transfers (CCT) increased completion of syphilis treatment among a community sample in a border city of Colombia.</div></div><div><h3>Methods</h3><div>We embedded a quasi-experimental trial of a CCT intervention in a community sexual health program serving participants aged 14 years and older in low-income settlements around Cúcuta, Colombia in 2023. The program included workshops and syphilis screening. Individuals with laboratory-confirmed syphilis were eligible for inclusion in the trial. Both control and CCT arms provided syphilis diagnostics, counseling and free treatment. CCT consisted of cash payments of USD$12.69 for completion of each of two follow-up treatments. We used generalized linear models to estimate the effect of CCT on treatment completion, defined as three doses of penicillin.</div></div><div><h3>Findings</h3><div>Of 1751 workshop participants, 114 had laboratory-confirmed syphilis and were enrolled in the trial. Participants were 56% female (64/114) and 44% male (50/114), with 6 participants (5.3%) identifying as transgender, regardless of sex at birth. Participants included 47% Venezuelan migrants staying in Cúcuta (53/114), 26% Colombian returnees (30/114), and 19% Colombians from the host community (22/114). Data on ethnicity was not collected. Median age was 34.5 years (IQR: 25.0–46.0). More than three-quarters (78%, 39/50) of CCT participants completed the three-dose treatment regimen compared to 45% (29/64) of control participants, a risk difference of 33% (p &lt; 0.001). In adjusted models, CCT-assigned participants had a 36% higher treatment completion rate compared to control-assigned participants (adjusted risk difference: aRD: 0.36, 95% CI: 0.19–0.53).</div></div><div><h3>Interpretation</h3><div>Conditional cash transfers might enhance syphilis treatment adherence among populations facing socioeconomic challenges.</div></div><div><h3>Funding</h3><div><span>German Development Cooperation Agency</span>, <span>Deutsche Gesellschaft für Internationale Zusammenarbeit</span>.</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"53 ","pages":"Article 101301"},"PeriodicalIF":7.0,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145526894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Clinical and economic impact of the availability of innovative therapies for advanced lung cancer in men in Latin America: a population-based secondary data study”- the Lancet Regional Health—Americas 2025; Volume 49: 101172; DOI: 10.1016/j.lana.2025.101172 “拉丁美洲男性晚期肺癌创新疗法可得性的临床和经济影响:基于人群的二级数据研究”的勘误表——《柳叶刀-美洲区域健康2025》;卷49:101172;DOI: 10.1016 / j.lana.2025.101172
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-14 DOI: 10.1016/j.lana.2025.101300
Andrés F. Cardona , Natalia Sánchez , Liliana Gutiérrez-Babativ , Leonardo Rojas , Jairo Zuluaga , Stella Martínez , Lucia Viola , Carlos Carvajal , Juliana Bogoya , Laura Prieto-Pinto , Daniel Samacá-Samacá , Antonio Robles , Joshua Kock , Claudio Martín , Luis Corrales , Luis E. Raez , Vladmir Cordeiro de Lima , Suraj Samtani , Oscar Arrieta
{"title":"Corrigendum to “Clinical and economic impact of the availability of innovative therapies for advanced lung cancer in men in Latin America: a population-based secondary data study”- the Lancet Regional Health—Americas 2025; Volume 49: 101172; DOI: 10.1016/j.lana.2025.101172","authors":"Andrés F. Cardona ,&nbsp;Natalia Sánchez ,&nbsp;Liliana Gutiérrez-Babativ ,&nbsp;Leonardo Rojas ,&nbsp;Jairo Zuluaga ,&nbsp;Stella Martínez ,&nbsp;Lucia Viola ,&nbsp;Carlos Carvajal ,&nbsp;Juliana Bogoya ,&nbsp;Laura Prieto-Pinto ,&nbsp;Daniel Samacá-Samacá ,&nbsp;Antonio Robles ,&nbsp;Joshua Kock ,&nbsp;Claudio Martín ,&nbsp;Luis Corrales ,&nbsp;Luis E. Raez ,&nbsp;Vladmir Cordeiro de Lima ,&nbsp;Suraj Samtani ,&nbsp;Oscar Arrieta","doi":"10.1016/j.lana.2025.101300","DOIUrl":"10.1016/j.lana.2025.101300","url":null,"abstract":"","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"52 ","pages":"Article 101300"},"PeriodicalIF":7.0,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145520198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Suicide-related outcomes in veterans with post-traumatic headache: a retrospective cohort study 创伤后头痛退伍军人的自杀相关结果:一项回顾性队列研究
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-13 DOI: 10.1016/j.lana.2025.101299
Sarah E. Anthony , Manali A. Phadke , Richard B. Lipton , Daniel G. Rogers , Lisa A. Brenner , John P. Ney , Hamada H. Altalib , X. Michelle Androulakis , Amy S. Grinberg , Melissa Skanderson , Hung-Mo Lin , Joel D. Scholten , Brenda T. Fenton , Elizabeth K. Seng , Jason J. Sico

Background

Post-traumatic headache (PTH) is a common sequela of traumatic brain injury (TBI). Although there is a known association between TBI and suicide risk in veterans, the association between PTH and suicide-related outcomes in veterans with TBI is relatively unknown. We aimed to evaluate the association between PTH and suicide-related outcomes in veterans compared to matched controls diagnosed with TBI but no history of headaches.

Methods

This retrospective cohort study was conducted with Veterans Health Administration and Department of Defense electronic health record data from fiscal years 2008 through 2020. Veterans with PTH were matched to a control group who had TBI and no headache disorders. Relative risk was estimated using propensity score-weighted log-binomial models that evaluated differences in suicidal ideation, suicide attempts, and suicide death.

Findings

Of the 95,224 veterans included in the total sample, 85,730 were male (90.0%) and 9,949 were female (10.0%). The average age of the sample was 45.9 years (SD = 16.6). 73,500 (77.2%) were White, Non-Hispanic, 17,256 (18.1%) were Black, Non-Hispanic, and 4,468 (4.7%) were classified as other or mixed race. Of the 47,612 veterans diagnosed with PTH, 4,618 (9.7%) reported suicidal ideation or suicide attempts compared to 3,162 (6.6%) in the control group. Veterans with PTH had increased risk of suicidal ideation (RR, 1.45; 95% CI, 1.39–1.51) and suicide attempts (RR, 1.66; 95% CI, 1.50–1.83) compared to matched controls. Using inverse probability weighting to adjust for confounding, these results remained significant. When adjusting for potential confounders, as well as prior suicidal ideation or suicide attempts, there was no significant difference in risk of suicide death in veterans with PTH (RR, 0.83; 95% CI, 0.67–1.02) compared to those with TBI without headache.

Interpretation

Veterans with PTH have an increased risk of suicidal ideation and suicide attempts compared to veterans with TBI and without headache. There was no difference in suicide mortality between the two groups. Clinicians should be aware of heightened suicide risk among veterans with PTH and be especially diligent in terms of screening for suicide risk and related medical and mental health comorbidities that contribute to increased risk.

Funding

This study was supported by the United States Department of Veterans Affairs special purpose medical service funding (SP80DPE.1-0160).
背景:创伤后头痛(PTH)是创伤性脑损伤(TBI)的常见后遗症。虽然已知创伤性脑损伤与退伍军人自杀风险之间存在关联,但PTH与创伤性脑损伤退伍军人自杀相关结果之间的关联相对未知。我们的目的是评估PTH与退伍军人自杀相关结果之间的关系,与诊断为TBI但没有头痛史的对照组相比。方法采用2008 - 2020财政年度退伍军人健康管理局和国防部电子健康记录数据进行回顾性队列研究。患有甲状旁腺激素的退伍军人与没有头痛疾病的TBI对照组相匹配。使用倾向评分加权对数二项模型估计相对风险,评估自杀意念、自杀企图和自杀死亡的差异。结果:在总样本的95224名退伍军人中,男性85730人(90.0%),女性9949人(10.0%)。样本平均年龄为45.9岁(SD = 16.6)。73,500人(77.2%)为白人,非西班牙裔,17,256人(18.1%)为黑人,非西班牙裔,4,468人(4.7%)为其他或混合种族。在47,612名被诊断患有甲状旁腺激素的退伍军人中,4,618名(9.7%)报告有自杀意念或自杀企图,而对照组为3,162名(6.6%)。与对照组相比,患有甲状旁腺激素的退伍军人有自杀意念(RR, 1.45; 95% CI, 1.39-1.51)和自杀企图(RR, 1.66; 95% CI, 1.50-1.83)的风险增加。使用逆概率加权来调整混杂因素,这些结果仍然显著。当调整潜在混杂因素,以及先前的自杀意念或自杀企图时,与没有头痛的TBI患者相比,PTH退伍军人的自杀死亡风险没有显著差异(RR, 0.83; 95% CI, 0.67-1.02)。与创伤性脑损伤和无头痛的退伍军人相比,患有甲状旁腺激素的退伍军人有更高的自杀意念和自杀企图的风险。两组之间的自杀死亡率没有差异。临床医生应该意识到患有甲状旁腺瘤的退伍军人自杀风险的增加,并在筛查自杀风险和相关的医疗和精神健康合并症方面特别勤奋,这些合并症会增加自杀风险。本研究由美国退伍军人事务部特殊目的医疗服务基金(SP80DPE.1-0160)支持。
{"title":"Suicide-related outcomes in veterans with post-traumatic headache: a retrospective cohort study","authors":"Sarah E. Anthony ,&nbsp;Manali A. Phadke ,&nbsp;Richard B. Lipton ,&nbsp;Daniel G. Rogers ,&nbsp;Lisa A. Brenner ,&nbsp;John P. Ney ,&nbsp;Hamada H. Altalib ,&nbsp;X. Michelle Androulakis ,&nbsp;Amy S. Grinberg ,&nbsp;Melissa Skanderson ,&nbsp;Hung-Mo Lin ,&nbsp;Joel D. Scholten ,&nbsp;Brenda T. Fenton ,&nbsp;Elizabeth K. Seng ,&nbsp;Jason J. Sico","doi":"10.1016/j.lana.2025.101299","DOIUrl":"10.1016/j.lana.2025.101299","url":null,"abstract":"<div><h3>Background</h3><div>Post-traumatic headache (PTH) is a common sequela of traumatic brain injury (TBI). Although there is a known association between TBI and suicide risk in veterans, the association between PTH and suicide-related outcomes in veterans with TBI is relatively unknown. We aimed to evaluate the association between PTH and suicide-related outcomes in veterans compared to matched controls diagnosed with TBI but no history of headaches.</div></div><div><h3>Methods</h3><div>This retrospective cohort study was conducted with Veterans Health Administration and Department of Defense electronic health record data from fiscal years 2008 through 2020. Veterans with PTH were matched to a control group who had TBI and no headache disorders. Relative risk was estimated using propensity score-weighted log-binomial models that evaluated differences in suicidal ideation, suicide attempts, and suicide death.</div></div><div><h3>Findings</h3><div>Of the 95,224 veterans included in the total sample, 85,730 were male (90.0%) and 9,949 were female (10.0%). The average age of the sample was 45.9 years (SD = 16.6). 73,500 (77.2%) were White, Non-Hispanic, 17,256 (18.1%) were Black, Non-Hispanic, and 4,468 (4.7%) were classified as other or mixed race. Of the 47,612 veterans diagnosed with PTH, 4,618 (9.7%) reported suicidal ideation or suicide attempts compared to 3,162 (6.6%) in the control group. Veterans with PTH had increased risk of suicidal ideation (RR, 1.45; 95% CI, 1.39–1.51) and suicide attempts (RR, 1.66; 95% CI, 1.50–1.83) compared to matched controls. Using inverse probability weighting to adjust for confounding, these results remained significant. When adjusting for potential confounders, as well as prior suicidal ideation or suicide attempts, there was no significant difference in risk of suicide death in veterans with PTH (RR, 0.83; 95% CI, 0.67–1.02) compared to those with TBI without headache.</div></div><div><h3>Interpretation</h3><div>Veterans with PTH have an increased risk of suicidal ideation and suicide attempts compared to veterans with TBI and without headache. There was no difference in suicide mortality between the two groups. Clinicians should be aware of heightened suicide risk among veterans with PTH and be especially diligent in terms of screening for suicide risk and related medical and mental health comorbidities that contribute to increased risk.</div></div><div><h3>Funding</h3><div>This study was supported by the United States <span>Department of Veterans Affairs</span> special purpose medical service funding (SP80DPE.1-0160).</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"53 ","pages":"Article 101299"},"PeriodicalIF":7.0,"publicationDate":"2025-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145526893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reconceptualizing access: advancing pharmaceutical equity for health system resilience in Central and South America 重新定义可及性:促进药品公平,促进中美洲和南美洲卫生系统的复原力
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-13 DOI: 10.1016/j.lana.2025.101302
Esteban Zavaleta-Monestel, Sebastián Arguedas-Chacón
{"title":"Reconceptualizing access: advancing pharmaceutical equity for health system resilience in Central and South America","authors":"Esteban Zavaleta-Monestel,&nbsp;Sebastián Arguedas-Chacón","doi":"10.1016/j.lana.2025.101302","DOIUrl":"10.1016/j.lana.2025.101302","url":null,"abstract":"","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"53 ","pages":"Article 101302"},"PeriodicalIF":7.0,"publicationDate":"2025-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145526892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oil spill in Esmeraldas: a public health emergency in the context of environmental racism 埃斯梅拉达斯石油泄漏:环境种族主义背景下的公共卫生紧急事件
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-07 DOI: 10.1016/j.lana.2025.101297
Jesús Endara-Mina , Damary S. Jaramillo-Aguilar , Katherine Simbaña-Rivera
{"title":"Oil spill in Esmeraldas: a public health emergency in the context of environmental racism","authors":"Jesús Endara-Mina ,&nbsp;Damary S. Jaramillo-Aguilar ,&nbsp;Katherine Simbaña-Rivera","doi":"10.1016/j.lana.2025.101297","DOIUrl":"10.1016/j.lana.2025.101297","url":null,"abstract":"","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"53 ","pages":"Article 101297"},"PeriodicalIF":7.0,"publicationDate":"2025-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145468229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Weak enforcement of Brazil's E-cigarette ban and the expansion of a dangerous illicit market 巴西电子烟禁令执行不力,危险的非法市场不断扩大
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-06 DOI: 10.1016/j.lana.2025.101294
Vitoria Borges Spinola , Lucas Porto Santos , Hamilton Roschel , Bruno Gualano , Megan E. Roberts
{"title":"Weak enforcement of Brazil's E-cigarette ban and the expansion of a dangerous illicit market","authors":"Vitoria Borges Spinola ,&nbsp;Lucas Porto Santos ,&nbsp;Hamilton Roschel ,&nbsp;Bruno Gualano ,&nbsp;Megan E. Roberts","doi":"10.1016/j.lana.2025.101294","DOIUrl":"10.1016/j.lana.2025.101294","url":null,"abstract":"","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"52 ","pages":"Article 101294"},"PeriodicalIF":7.0,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145466152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thirty-five years of Brazil's Unified Health System (SUS): from Alma-ata to the climate challenge 巴西统一卫生系统(SUS) 35年:从阿拉木图到气候挑战
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-01 DOI: 10.1016/j.lana.2025.101295
Alexandre Padilha , Adriano Massuda , Florentino Leônidas , Andreza Davidian
{"title":"Thirty-five years of Brazil's Unified Health System (SUS): from Alma-ata to the climate challenge","authors":"Alexandre Padilha ,&nbsp;Adriano Massuda ,&nbsp;Florentino Leônidas ,&nbsp;Andreza Davidian","doi":"10.1016/j.lana.2025.101295","DOIUrl":"10.1016/j.lana.2025.101295","url":null,"abstract":"","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"51 ","pages":"Article 101295"},"PeriodicalIF":7.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145465811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends of incident adult Attention-deficit/hyperactivity disorder diagnoses before, during and after the pandemic provincial state of emergency in British Columbia (2013–2023): a population-based study 不列颠哥伦比亚省(2013-2023年)大流行省紧急状态之前、期间和之后成人注意缺陷/多动障碍诊断事件的趋势:一项基于人群的研究
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-01 DOI: 10.1016/j.lana.2025.101223
Kevin Hu , Roshni Desai , Shania Au , Bin Zhao , Skye Barbic , Kirsten Marchand , Tonia Nicholls , Christian Schütz , Hasina Samji , Jia Hu , Geoff McKee , Alexis Crabtree , Heather Palis

Background

Emerging evidence indicates a potential rise in attention-deficit/hyperactivity disorder (ADHD) incidence worldwide and in British Columbia (BC) since the pandemic. Given the high comorbidity of ADHD with substance use disorder (SUD) and other mental disorders, understanding changes in ADHD diagnosis among adults is crucial for healthcare planning amid BC's drug poisoning (overdose) crisis. We aimed to report how rates of newly diagnosed adult ADHD changed before, during and after the pandemic by demographic variables and histories of SUD or mental disorders.

Methods

We conducted interrupted time series analyses on overall and stratified monthly incidence rates of ADHD diagnosis between Jan, 2013, and Nov, 2023 in BC, using data from linked population-based administrative databases.

Findings

The pre-pandemic average of newly diagnosed adult ADHD was 8.8 cases per 100,000 population monthly. During the pandemic (Mar, 2020–Jun, 2021), this rose to 19.2 driven by a 4.9% (95% confidence interval: [3.7, 6.2]) month-over-month increase. When the pandemic ended, the monthly rate jumped by 107.3% [68.5, 155.0] in Jul, 2021 and grew 1.5% [0.4, 2.7] per month thereafter, averaging 34.8 cases per 100,000 post-pandemic. Substantial differences in trends emerged when stratified by sex and SUD histories.

Interpretation

This exponential rise in adult ADHD may be explained by pandemic-related sociocultural changes and the broader societal evolution in mental health awareness in recent years and decades. This rise could foreshadow a potential increase in the population at risk of SUD, underscoring the urgent need for bidirectional integration of ADHD and SUD services.

Funding

We acknowledge the UBC Psychiatry Stimulus Grants Initiative.
背景:新出现的证据表明,自大流行以来,全球和不列颠哥伦比亚省的注意力缺陷/多动障碍(ADHD)发病率可能上升。鉴于ADHD与物质使用障碍(SUD)和其他精神障碍的高合并症,了解成人ADHD诊断的变化对于BC省药物中毒(过量)危机中的医疗保健计划至关重要。我们的目的是通过人口统计学变量和SUD或精神障碍史,报告新诊断的成人ADHD在大流行之前、期间和之后的变化情况。方法:我们对2013年1月至2023年11月不列颠哥伦比亚省ADHD诊断的总体和分层月发病率进行了中断时间序列分析,使用的数据来自相关的基于人群的管理数据库。研究结果:在流感大流行前,新诊断的成人多动症平均每月每10万人中有8.8例。在大流行期间(2020年3月至2021年6月),由于逐月增长4.9%(95%置信区间:[3.7,6.2]),这一数字上升至19.2。大流行结束后,2021年7月每月发病率上升107.3%[68.5,155.0],此后每月增长1.5%[0.4,2.7],平均每10万例34.8例。当按性别和SUD病史分层时,趋势出现了实质性差异。成人多动症的指数增长可能是由近年来和几十年来与流行病相关的社会文化变化和心理健康意识的更广泛的社会演变所解释的。这一上升可能预示着有SUD风险的人群可能会增加,强调了ADHD和SUD服务双向整合的迫切需要。我们承认UBC精神病学刺激资助计划。
{"title":"Trends of incident adult Attention-deficit/hyperactivity disorder diagnoses before, during and after the pandemic provincial state of emergency in British Columbia (2013–2023): a population-based study","authors":"Kevin Hu ,&nbsp;Roshni Desai ,&nbsp;Shania Au ,&nbsp;Bin Zhao ,&nbsp;Skye Barbic ,&nbsp;Kirsten Marchand ,&nbsp;Tonia Nicholls ,&nbsp;Christian Schütz ,&nbsp;Hasina Samji ,&nbsp;Jia Hu ,&nbsp;Geoff McKee ,&nbsp;Alexis Crabtree ,&nbsp;Heather Palis","doi":"10.1016/j.lana.2025.101223","DOIUrl":"10.1016/j.lana.2025.101223","url":null,"abstract":"<div><h3>Background</h3><div>Emerging evidence indicates a potential rise in attention-deficit/hyperactivity disorder (ADHD) incidence worldwide and in British Columbia (BC) since the pandemic. Given the high comorbidity of ADHD with substance use disorder (SUD) and other mental disorders, understanding changes in ADHD diagnosis among adults is crucial for healthcare planning amid BC's drug poisoning (overdose) crisis. We aimed to report how rates of newly diagnosed adult ADHD changed before, during and after the pandemic by demographic variables and histories of SUD or mental disorders.</div></div><div><h3>Methods</h3><div>We conducted interrupted time series analyses on overall and stratified monthly incidence rates of ADHD diagnosis between Jan, 2013, and Nov, 2023 in BC, using data from linked population-based administrative databases.</div></div><div><h3>Findings</h3><div>The pre-pandemic average of newly diagnosed adult ADHD was 8.8 cases per 100,000 population monthly. During the pandemic (Mar, 2020–Jun, 2021), this rose to 19.2 driven by a 4.9% (95% confidence interval: [3.7, 6.2]) month-over-month increase. When the pandemic ended, the monthly rate jumped by 107.3% [68.5, 155.0] in Jul, 2021 and grew 1.5% [0.4, 2.7] per month thereafter, averaging 34.8 cases per 100,000 post-pandemic. Substantial differences in trends emerged when stratified by sex and SUD histories.</div></div><div><h3>Interpretation</h3><div>This exponential rise in adult ADHD may be explained by pandemic-related sociocultural changes and the broader societal evolution in mental health awareness in recent years and decades. This rise could foreshadow a potential increase in the population at risk of SUD, underscoring the urgent need for bidirectional integration of ADHD and SUD services.</div></div><div><h3>Funding</h3><div>We acknowledge the <span>UBC Psychiatry Stimulus Grants Initiative</span>.</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"51 ","pages":"Article 101223"},"PeriodicalIF":7.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145519872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why have overdose deaths decreased? Widespread fentanyl saturation and decreased drug use among key drivers 为什么过量用药导致的死亡减少了?芬太尼饱和和药物使用减少是主要驱动因素
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-01 DOI: 10.1016/j.lana.2025.101226
Deborah Dowell, Nisha Nataraj, Michaela Rikard, Joohyun Park, Kun Zhang, Grant Baldwin
While overdose deaths remain high in the United States (U.S.), national data show a 25.0% decline in overdose deaths from the year ending in March 2025 compared to the previous year. Reductions since 2015 in the population exposed to overdose risk through drug use may have until recently been offset by an increased per-person mortality risk, driven by replacement of heroin with fentanyl in the drug supply. We estimated overdose deaths and counterfactual scenarios from 2016 to 2023. An estimated 109,783 additional people would have died from opioid overdose if the population exposed to opioid overdose risk had remained constant rather than declining; an estimated 260,024 fewer people would have died from overdose if probability of fentanyl involvement in opioid overdose deaths had remained constant rather than increasing. Fentanyl's representation in the U.S. drug supply appears to be a key driver of overdose trends. A declining population exposed to overdose risk over the last decade may be related to prior deaths and to evidence-based efforts to prevent substance use and opioid use disorder.
虽然美国的过量死亡人数仍然很高,但国家数据显示,与前一年相比,截至2025年3月的一年过量死亡人数下降了25.0%。自2015年以来,因吸毒而面临过量风险的人口数量有所减少,但直到最近,由于在药物供应中以芬太尼替代海洛因,导致人均死亡风险增加,这可能被抵消了。我们估计了2016年至2023年的过量死亡和反事实情景。如果暴露于阿片类药物过量风险的人口保持不变而不是下降,估计会有109,783人额外死于阿片类药物过量;如果芬太尼参与阿片类药物过量死亡的概率保持不变而不是增加,估计死于过量服用的人数将减少26024人。芬太尼在美国药物供应中的代表性似乎是过量趋势的关键驱动因素。在过去十年中,面临过量风险的人口减少可能与以前的死亡和以证据为基础的预防药物使用和阿片类药物使用障碍的努力有关。
{"title":"Why have overdose deaths decreased? Widespread fentanyl saturation and decreased drug use among key drivers","authors":"Deborah Dowell,&nbsp;Nisha Nataraj,&nbsp;Michaela Rikard,&nbsp;Joohyun Park,&nbsp;Kun Zhang,&nbsp;Grant Baldwin","doi":"10.1016/j.lana.2025.101226","DOIUrl":"10.1016/j.lana.2025.101226","url":null,"abstract":"<div><div>While overdose deaths remain high in the United States (U.S.), national data show a 25.0% decline in overdose deaths from the year ending in March 2025 compared to the previous year. Reductions since 2015 in the population exposed to overdose risk through drug use may have until recently been offset by an increased per-person mortality risk, driven by replacement of heroin with fentanyl in the drug supply. We estimated overdose deaths and counterfactual scenarios from 2016 to 2023. An estimated 109,783 additional people would have died from opioid overdose if the population exposed to opioid overdose risk had remained constant rather than declining; an estimated 260,024 fewer people would have died from overdose if probability of fentanyl involvement in opioid overdose deaths had remained constant rather than increasing. Fentanyl's representation in the U.S. drug supply appears to be a key driver of overdose trends. A declining population exposed to overdose risk over the last decade may be related to prior deaths and to evidence-based efforts to prevent substance use and opioid use disorder.</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"51 ","pages":"Article 101226"},"PeriodicalIF":7.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145519871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CBPR is indeed political CBPR确实是政治性的
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-01 DOI: 10.1016/j.lana.2025.101293
Rebekah Israel Cross , James Huynh , Taylor B. Rogers , Natalie J. Bradford , Mienah Z. Sharif
{"title":"CBPR is indeed political","authors":"Rebekah Israel Cross ,&nbsp;James Huynh ,&nbsp;Taylor B. Rogers ,&nbsp;Natalie J. Bradford ,&nbsp;Mienah Z. Sharif","doi":"10.1016/j.lana.2025.101293","DOIUrl":"10.1016/j.lana.2025.101293","url":null,"abstract":"","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"51 ","pages":"Article 101293"},"PeriodicalIF":7.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145416572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Lancet Regional Health-Americas
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1